Key result
This document is an erratum correcting the funding section of a previously published paper regarding the ESC Heart Failure Long-Term Registry.
This is an erratum correcting the funding section of the ESC-HF-LT registry publication.
Answers are grounded in this paper and cite their sources.
Highlights persistent GDMT gaps across European HF phenotypes; leaves open questions on barriers for targeted implementation research.
Maria G. Crespo-Leiro, Stefan D. Anker, Aldo P. Maggioni, Andrew J. Coats, Gerasimos Filippatos, Frank Ruschitzka, Roberto Ferrari, Massimo Francesco Piepoli, Juan F. Delgado Jimenez, Marco Metra, Candida Fonseca, Jaromir Hradec, Offer Amir, Damien Logeart, Ulf Dahlström, Bela Merkely, Jaroslaw Drozdz, Eva Goncalvesova, Mahmoud Hassanein, Ovidiu Chioncel, Mitja Lainscak, Petar M. Seferovic, Dimitris Tousoulis, Ausra Kavoliuniene, Friedrich Fruhwald, Emir Fazlibegovic, Ahmet Temizhan, Plamen Gatzov, Andrejs Erglis, Cécile Laroche, and Alexandre Mebazaa, on behalf of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Following the publication of Crespo-Leiro et al.1 some errors were identified in the companies listed in the Funding section, and the period of their involvement. The Funding section should read: “Since the start of EORP, the following companies have supported the programme: Abbott Vascular Int. (2011–2014), Amgen Cardiovascular (2009–2018), AstraZeneca (2014–2017), Bayer (2009–2018), Boehringer Ingelheim (2009–2016), Boston Scientific (2009–2012), The Bristol Myers Squibb and Pfizer Alliance (2011–2016), The Alliance Daiichi Sankyo Europe GmbH and Eli Lilly and Company (2011–2017), Gedeon Richter Plc. (2014–2017), Menarini Int. Op. (2009–2012), MSD-Merck & Co. (2011–2014), Novartis Pharma AG (2014–2017), ResMed (2014–2016), Sanofi (2009–2011), SERVIER (2009–2018).”
No takes yet. Share an insight, caveat, or question.
A 2017 study studied Heart Failure. This document is an erratum correcting the funding section of a previously published paper regarding the ESC Heart Failure Long-Term Registry.
Synapse has enriched 10 related papers. Consider them for comparative context: